MLEC vs. CHRS
MLEC (Moolec Science SA Ordinary Shares) and CHRS (Coherus BioSciences, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, MLEC returned -74.87%/yr vs -28.47%/yr for CHRS. At a correlation of -0.02, they often move in opposite directions.
Performance
MLEC vs. CHRS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLEC achieves a 109.48% return, which is significantly higher than CHRS's 2.82% return.
MLEC
- 1D
- 0.13%
- 1M
- 2.96%
- YTD
- 109.48%
- 6M
- 130.28%
- 1Y
- -92.40%
- 3Y*
- -74.87%
- 5Y*
- —
- 10Y*
- —
CHRS
- 1D
- -1.35%
- 1M
- -9.32%
- YTD
- 2.82%
- 6M
- 10.61%
- 1Y
- 100.91%
- 3Y*
- -28.47%
- 5Y*
- -37.42%
- 10Y*
- -20.95%
MLEC vs. CHRS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MLEC Moolec Science SA Ordinary Shares | 109.48% | -96.82% | -67.48% | -75.40% |
CHRS Coherus BioSciences, Inc. | 2.82% | 2.90% | -58.56% | -57.95% |
Correlation
The correlation between MLEC and CHRS is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2023 | -0.02 |
Fundamentals
MLEC:
$7.83M
CHRS:
$46.88M
MLEC:
-$639.50K
CHRS:
$23.41M
MLEC:
-$5.21M
CHRS:
-$162.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLEC vs. CHRS — Risk / Return Rank
MLEC
CHRS
MLEC vs. CHRS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Moolec Science SA Ordinary Shares (MLEC) and Coherus BioSciences, Inc. (CHRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLEC | CHRS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.69 | ||
| Sortino ratioReturn per unit of downside risk | -2.87 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.24 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 2.21 | -3.17 |
| Martin ratioReturn relative to average drawdown | -1.07 | 4.18 | -5.25 |
Loading charts...
Drawdowns
MLEC vs. CHRS - Drawdown Comparison
The maximum MLEC drawdown since its inception was -99.88%, roughly equal to the maximum CHRS drawdown of -98.21%. Use the drawdown chart below to compare losses from any high point for MLEC and CHRS.
Loading charts...
Drawdown Indicators
| MLEC | CHRS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.88% | -98.21% | -1.67% |
Max Drawdown (1Y)Largest decline over 1 year | -97.07% | -45.82% | -51.25% |
Max Drawdown (3Y)Largest decline over 3 years | -99.41% | -87.71% | -11.70% |
Max Drawdown (5Y)Largest decline over 5 years | — | -96.47% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.88% | — |
Current DrawdownCurrent decline from peak | -99.72% | -96.10% | -3.62% |
Average DrawdownAverage peak-to-trough decline | -91.76% | -63.61% | -28.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 86.13% | 24.24% | +61.89% |
Volatility
MLEC vs. CHRS - Volatility Comparison
Moolec Science SA Ordinary Shares (MLEC) has a higher volatility of 25.12% compared to Coherus BioSciences, Inc. (CHRS) at 16.46%. This indicates that MLEC's price experiences larger fluctuations and is considered to be riskier than CHRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLEC | CHRS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.12% | 16.46% | +8.66% |
Volatility (6M)Calculated over the trailing 6-month period | 161.46% | 59.75% | +101.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 206.28% | 81.79% | +124.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.82% | 84.83% | +111.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.82% | 74.95% | +121.87% |
Dividends
MLEC vs. CHRS - Dividend Comparison
Neither MLEC nor CHRS has paid dividends to shareholders.
Financials
MLEC vs. CHRS - Financials Comparison
This section allows you to compare key financial metrics between Moolec Science SA Ordinary Shares and Coherus BioSciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLEC and CHRS have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MLEC has higher volatility (25.12%) compared to CHRS (16.46%). In terms of maximum drawdown, MLEC dropped -99.88% vs CHRS's -98.21%.
CHRS currently has the higher Sharpe Ratio (1.24 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MLEC and CHRS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer